NWBO shareholders OK share increase to 2.6B, elect Pat Sarma

NORTHWEST BIOTHERAPEUTICS INC

Authorized common shares increased from 1.7B to 2.6B; 89.65% of votes cast in favor.
Over 77% of total voting power represented at annual meeting; quorum present.
Pat Sarma elected as Class II director for three-year term with 81.1% of votes for.
Ratified Cherry Bekaert LLP as independent auditor for FY2025 (93.76% for).
Advisory vote on executive compensation approved with 77.23% of votes for.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

NORTHWEST BIOTHERAPEUTICS INC: Increased authorized shares of common stock from 1,700,000,000 to 2,600,000,000 (effective 2025-12-30).

Change: charter amendment
Effective: 2025-12-30

Exact text from the filing

On December 30, 2025, the Company filed a Certificate of Amendment of its Amended and Restated Certificate of Incorporation (the “Certificate of Amendment”) with the Secretary of the State of Delaware, which effected an increase in the Company’s authorized shares of common stock, from 1,700,000,000 to 2.600,000,000, par value $0.001 per share.

View on SEC.gov

Browse all governance changes →

NORTHWEST BIOTHERAPEUTICS INC filing history →

Source: SEC EDGAR

accession 0001104659-26-000243

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.